In this setting, TMPRSS2 represents a valid target in COVID‐19 treatment and miR‐98‐5p is a suitable candidate; miR‐98 directly targets the 3′UTR of TMPRSS, having a key role in the regulation of endothelial function.28 Here, TMPRSS2 is linked to COVID-19.